How it may work
A copper-binding tripeptide studied in extracellular-matrix, wound and skin biology.
Guide-level evidence orientationEvidence level E
Level E marks a central question without dependable direct human evidence; read the outcome conclusion rather than treating the letter as a direction of effect.
This guide-level grade is an orientation, not a direction-of-effect label, product grade, claim or personal recommendation.Why people are interested
A copper-binding peptide studied in skin, wound and connective-tissue biology. Topical interest does not prove a whole-body longevity effect.
Library trackMedical research
Last reviewed20 Aug 2026
Guide scopeIngredient research only
What people have studied
Topical and mechanistic interest does not establish systemic longevity benefit.
What to consider
Route, copper exposure, sterility and product identity materially change risk.
Local pathway
Research/medical classification requires route-specific review. Not sold by CELLIVITY.
Sources + indexes
See where the explanation comes from.
Open the linked research and official records behind this guide. Early topics may begin with a research index while stronger sources are added.